RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Clearpoint Neuro Stock

Clearpoint Neuro Revenue 2024

Clearpoint Neuro Revenue

31.13 M USD

Ticker

CLPT

ISIN

US18507C1036

WKN

A2PZ3E

In 2024, Clearpoint Neuro's sales reached 31.13 M USD, a 29.95% difference from the 23.96 M USD sales recorded in the previous year.

The Clearpoint Neuro Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2026e58.9623,09
2025e39.3834,57
2024e31.1343,73
202323.9656,83
202220.5565,84
202116.369,26
202012.8371,08
201911.2265,78
20187.3566,94
20177.3860,70
20165.7554,09
20154.5956,86
20143.646,67
20133.9363,87
20125.0688,93
20113.8282,72
20102.6799,25
20092.6100,00
20081.95100,00
2007--
2006--
20050.34538,00

Clearpoint Neuro Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Clearpoint Neuro, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Clearpoint Neuro from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Clearpoint Neuro’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Clearpoint Neuro. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Clearpoint Neuro’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Clearpoint Neuro’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Clearpoint Neuro’s growth potential.

Clearpoint Neuro Revenue, EBIT and net profit per share

DateClearpoint Neuro RevenueClearpoint Neuro EBITClearpoint Neuro Net Income
2026e58.96 M undefined-19.18 M undefined-18.18 M undefined
2025e39.38 M undefined-19.33 M undefined-18.55 M undefined
2024e31.13 M undefined-19.93 M undefined-19.81 M undefined
202323.96 M undefined-22.45 M undefined-22.09 M undefined
202220.55 M undefined-16.33 M undefined-16.44 M undefined
202116.3 M undefined-13.37 M undefined-14.41 M undefined
202012.83 M undefined-6.22 M undefined-6.78 M undefined
201911.22 M undefined-4.59 M undefined-5.54 M undefined
20187.35 M undefined-5.25 M undefined-6.16 M undefined
20177.38 M undefined-6.34 M undefined-7.17 M undefined
20165.75 M undefined-7.49 M undefined-8.07 M undefined
20154.59 M undefined-7.72 M undefined-8.45 M undefined
20143.6 M undefined-9.66 M undefined-4.52 M undefined
20133.93 M undefined-7.47 M undefined-7.09 M undefined
20125.06 M undefined-4.01 M undefined-5.88 M undefined
20113.82 M undefined-5.92 M undefined-8.31 M undefined
20102.67 M undefined-9.52 M undefined-9.45 M undefined
20092.6 M undefined-7.06 M undefined-7.16 M undefined
20081.95 M undefined-5.23 M undefined-5.43 M undefined
20070 undefined-3.51 M undefined-3.7 M undefined
20060 undefined-1.14 M undefined-800,000 undefined
2005300,000 undefined-920,000 undefined-950,000 undefined

Clearpoint Neuro stock margins

The Clearpoint Neuro margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Clearpoint Neuro. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Clearpoint Neuro.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Clearpoint Neuro's sales revenue. A higher gross margin percentage indicates that the Clearpoint Neuro retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Clearpoint Neuro's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Clearpoint Neuro's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Clearpoint Neuro's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Clearpoint Neuro. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Clearpoint Neuro's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Clearpoint Neuro Margin History

Clearpoint Neuro Gross marginClearpoint Neuro Profit marginClearpoint Neuro EBIT marginClearpoint Neuro Profit margin
2026e56.83 %-32.53 %-30.84 %
2025e56.83 %-49.1 %-47.11 %
2024e56.83 %-64.02 %-63.64 %
202356.83 %-93.7 %-92.21 %
202265.84 %-79.46 %-80 %
202169.26 %-82.02 %-88.4 %
202071.08 %-48.48 %-52.84 %
201965.78 %-40.91 %-49.38 %
201866.94 %-71.43 %-83.81 %
201760.7 %-85.91 %-97.15 %
201654.09 %-130.26 %-140.35 %
201556.86 %-168.19 %-184.1 %
201446.67 %-268.33 %-125.56 %
201363.87 %-190.08 %-180.41 %
201288.93 %-79.25 %-116.21 %
201182.72 %-154.97 %-217.54 %
201099.25 %-356.55 %-353.93 %
2009100 %-271.54 %-275.38 %
2008100 %-268.21 %-278.46 %
200756.83 %0 %0 %
200656.83 %0 %0 %
200556.83 %-306.67 %-316.67 %

Clearpoint Neuro Aktienanalyse

What does Clearpoint Neuro do?

Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and marketing of advanced medical products and systems. The company was founded in 1998 and is headquartered in Irvine, California. Clearpoint Neuro's primary goal is to provide better care and treatment for patients with neurological disorders. Clearpoint Neuro was originally founded in 1998 under the name MRI Intervention to meet the market demand for innovative navigation systems for minimally invasive brain procedures. The company's initial products included imaging devices used during surgery. Since then, the company has expanded its product portfolio and strengthened its market position by focusing on core tasks in the field of medical technology. In 2011, MRI Intervention rebranded as Clearpoint Neuro to accommodate its growing product portfolio. The company now primarily focuses on the development and marketing of platform technologies for the control of minimally invasive instruments during neurosurgical procedures. Its customers include hospitals and research institutions that specialize in neurological and neuroscience applications. Clearpoint Neuro has built an extremely successful business model that specializes in providing advanced medical technology to benefit patients. The company works closely with leading neurosurgeons and researchers to understand the needs of patients and develop the most advanced technologies aimed at improving patient treatment. Clearpoint Neuro is a B2B (Business to Business) company that sells its products and services to hospitals and research institutions to ensure that its products are used by medical professionals with appropriate education and experience. The company also has a strong presence in the academic world, where it focuses on collaborating with laboratories and universities to advance the latest developments in technology and research. The divisions of Clearpoint Neuro include medical product areas developed from its technology base, which are described in more detail in the following sections. ClearPoint System ClearPoint is an intraoperative MRI system that is available as a core component of neurosurgical intervention platforms. It uses advanced technology for real-time localization and navigation of instruments to perform minimally invasive brain surgeries. It utilizes imaging technologies to enable navigation and coordination during the surgical procedure. ClearPoint Neuro Therapies ClearPoint Neuro Therapies includes three main areas: "DBS," "MRI-Guided Focused Ultrasound," and "Laser Therapy." DBS (Deep Brain Stimulation) is a minimally invasive neural therapy that involves the insertion of thin electrodes into the brain using a specially existing surgical technique to treat degenerative diseases, particularly Parkinson's disease. Another highly innovative therapy option is MRI-Guided Focused Ultrasound therapy, which targets and precisely destroys cancer cells using focused ultrasound waves. ClearPoint Neuro is one of the leading providers of this advanced therapy. Laser therapy involves the destruction of selected neural cells using heat. ClearPoint Neuro Navigation ClearPoint Neuro's navigation technologies are leading in neurosurgery and research. Navigation allows for precise placement of needles in the brain to obtain biopsies under ultrasound guidance or to administer medication targetedly without damaging the brain. The system is used by neurosurgeons and researchers worldwide. In conclusion, Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and manufacturing of advanced systems and products for neurosurgery and research. The company has built a strong business model by working closely with leading neurosurgeons and researchers and developing the most advanced technologies aimed at improving the quality of patient care. The ClearPoint System, ClearPoint Neuro Therapies, and ClearPoint Neuro Navigation divisions play a significant role in its success. Clearpoint Neuro ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Clearpoint Neuro's Sales Figures

The sales figures of Clearpoint Neuro originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Clearpoint Neuro’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Clearpoint Neuro's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Clearpoint Neuro’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Clearpoint Neuro stock

How much revenue did Clearpoint Neuro generate this year?

Clearpoint Neuro has achieved a revenue of 31.13 M USD this year.

How much was the turnover of the company Clearpoint Neuro compared to the previous year?

The revenue of Clearpoint Neuro has increased by 29.95% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Clearpoint Neuro?

The revenue of Clearpoint Neuro is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Clearpoint Neuro measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Clearpoint Neuro so important for investors?

The revenue of Clearpoint Neuro is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Clearpoint Neuro pay?

Over the past 12 months, Clearpoint Neuro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Clearpoint Neuro is expected to pay a dividend of 0 USD.

What is the dividend yield of Clearpoint Neuro?

The current dividend yield of Clearpoint Neuro is .

When does Clearpoint Neuro pay dividends?

Clearpoint Neuro pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Clearpoint Neuro?

Clearpoint Neuro paid dividends every year for the past 0 years.

What is the dividend of Clearpoint Neuro?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Clearpoint Neuro located?

Clearpoint Neuro is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clearpoint Neuro kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clearpoint Neuro from 8/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/1/2024.

When did Clearpoint Neuro pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Clearpoint Neuro in the year 2023?

In the year 2023, Clearpoint Neuro distributed 0 USD as dividends.

In which currency does Clearpoint Neuro pay out the dividend?

The dividends of Clearpoint Neuro are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Clearpoint Neuro

Our stock analysis for Clearpoint Neuro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clearpoint Neuro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.